Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bivalent Coronavirus Disease 2019 Vaccine Antibody Responses to Omicron Variants Suggest That Responses to Divergent Variants Would Be Improved With Matched Vaccine Antigens
Wei Wang, Emilie Goguet, Stephanie Paz, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 4, pp. 439-443
Open Access | Times Cited: 15

Showing 15 citing articles:

Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
Annika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Neutralization of SARS‐CoV‐2 Omicron XBB.1.5 and JN.1 variants after COVID‐19 booster‐vaccination and infection
David Niklas Springer, Jeremy V. Camp, Stephan W. Aberle, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 7
Open Access | Times Cited: 7
Repeated Omicron exposures redirect SARS-CoV-2–specific memory B cell evolution toward the latest variants
Ryutaro Kotaki, Saya Moriyama, Shintaro Oishi, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 761
Closed Access | Times Cited: 4
Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster sera
Wei Wang, Gitanjali Bhushan, Stephanie Paz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates
Deborah Cromer, Arnold Reynaldi, Ainslie Mitchell, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Assessment of an in-house IgG ELISA targeting SARS-CoV-2 RBD: Applications in infected and vaccinated individuals
Hernan Hermes Monteiro da Costa, Valéria Oliveira Silva, Gustavo Carvalho Amorim, et al.
Journal of Immunological Methods (2024) Vol. 530, pp. 113683-113683
Closed Access | Times Cited: 2
Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1
Wei Wang, Gitanjali Bhushan, Stephanie Paz, et al.
Journal of Virology (2024)
Closed Access | Times Cited: 2
Diminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan
Tianchen Zhao, Yuta Tani, Chieko Makino‐Okamura, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Effectiveness of bivalent mRNA booster vaccination and previous infection in older adults during Omicron period: real-world evidence
Pedro Pablo España, Idoia Castillo-Sintes, María José Legarreta, et al.
Age and Ageing (2024) Vol. 53, Iss. 11
Closed Access | Times Cited: 1
Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates
Deborah Cromer, Arnold Reynaldi, Ainslie Hie, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Construction and efficacy testing of DNA vaccines containing HLA-A*02:01-restricted SARS-CoV-2 T-cell epitopes predicted by immunoinformatics
Dan Tan, Kang Ning, Yuanfei Zhu, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access
Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID‐19 booster dose in persons with HIV
Giulia Matusali, Alessandra Vergori, Eleonora Cimini, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Open Access
Evaluating the Quality of Studies Assessing COVID-19 Vaccine Neutralizing Antibody Immunogenicity
Maeva Katzmarzyk, Robert Naughton, Ioannis Sitaras, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1238-1238
Open Access
Robust generation of neutralising antibodies against Omicron variants following bivalent mRNA booster vaccine in elderly people aged >80 years
Helen Parry, Rachel Bruton, Grace Uwenedi, et al.
Journal of Infection (2023) Vol. 88, Iss. 1, pp. 48-50
Open Access
Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid Malignancies
Line Dam Heftdal, Cecilie Bo Hansen, Sebastian Rask Hamm, et al.
Viruses (2023) Vol. 16, Iss. 1, pp. 11-11
Open Access
Page 1

Scroll to top